Lv3
340 积分 2024-10-10 加入
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
1天前
已完结
Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition)
3天前
已完结
[Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer]
3天前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
17天前
已完结
Precision surgery for hepatocellular carcinoma
24天前
已完结
Prostate cancer
24天前
已完结
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer
24天前
已完结
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma
24天前
已完结
Synthetic lethal strategies for the development of cancer therapeutics
24天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
25天前
已完结
皖公网安备34019202002308
